Smith Jason Drew sold URGN
September 8, 2026 · Form 4 insider transaction
Smith Jason Drew sold 1,519 shares of UroGen Pharma Ltd. at $42.54 per share, a transaction worth $64.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,519
Price
$42.54
Total value
$64.6K
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2026
Filing dateSeptember 9, 2026
Shares owned after53,141
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.